• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Antibiotic Drug Discovery: New Targets and Molecular Entities

Antibiotic Drug Discovery: New Targets and Molecular Entities

9781782624240
1 064,70 zł
958,23 zł Zniżka 106,47 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 958,23 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis
Recent years have seen a resurgence of antibiotic drug discovery. This book brings together the relevant information to assess the state-of-the-art. It identifies and elaborates the most recent and compelling strategies for antibiotic drug discovery with a primary focus on new targets, mechanisms and molecular entities. Addressing the need for continued investment in antibiotic drug development, the book provides a point of reference for the rapidly expanding infectious disease research community. In addition to its attention on new targets, the book focusses on the medicinal chemistry and chemistry of the targets. Within this framework, chapters from leading researchers in academia and industry address findings in important areas such as biofilm production, narrow spectrum antibiotics and novel antibacterials from previously uncultured soil bacteria. This book will be a useful resource for postgraduate students and researchers in medicinal chemistry wishing to understand the latest approaches to antibiotic drug discovery.
Szczegóły produktu
77382
9781782624240
9781782624240

Opis

Rok wydania
2017
Numer wydania
1
Oprawa
twarda
Liczba stron
286
Wymiary (mm)
156.00 x 234.00
Waga (g)
582
  • Treatment of Clostridium difficile Infections; Targeting Purine Biosynthesis for Antibacterial Drug Design; Inhibitors of Biofilm Production; Narrow Spectrum Antibacterial Agents; The LPS Transport Pathway:: A New Target for the Development of Gram-Negative Antibiotics; The Discovery of Teixobactin; Emerging Targets in Anti-Tubercular Drug Design; Antibacterial Leads Targeting Isoprenoid Biosynthesis
Komentarze (0)